Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study

Background/Objectives: Transverse myelitis (TM) and acute disseminated encephalomyelitis (ADEM) are debilitating neurological conditions. We aimed to examine in-hospital mortality and readmissions in patients hospitalized with TM and/or ADEM. Methods: In this retrospective study, we analyzed the Nationwide Readmissions Database from 2010 to 2020, excluding 2015, to identify index hospitalizations for TM and/or ADEM. Patients were stratified according to in-hospital mortality status. We used the Pearson chi-square test and Wilcoxon rank-sum test to compare baseline characteristics, while multivariable logistic regression analysis was used to identify predictors of in-hospital mortality. Results: Of 50,357 patients hospitalized with TM and/or ADEM, 1236 (2.5%) did not survive index hospitalization. Nonsurvivors were older with longer lengths of stay and a higher comorbidity burden. Among those ≥45 years, there was a trend towards increased odds of in-hospital mortality. Infection-related factors were associated with increased odds of in-hospital mortality, including streptococcal infection (odds ratio [OR]: 5.45 [1.07–27.68], p = 0.04) and coronavirus disease 2019 (OR: 4.54 [2.51–8.19], p < 0.001). Stroke (OR 2.71 [2.11–3.48], p < 0.001) and congestive heart failure (OR 2.17 [1.66–2.85], p < 0.001) emerged as the strongest predictors amongst chronic comorbidities. Over the study period, 5301 (11.8%) patients were readmitted to the hospital within 30 days. Conclusions: In patients with TM and/or ADEM, in-hospital mortality was associated with older age, greater comorbidity burden, and concurrent infections, particularly COVID-19 and streptococcal infections. These findings highlight opportunities for prevention, early detection, and management strategies to improve outcomes for patients with TM and/or ADEM.

Authors

Institutions

Publication Details

Journal
Clinics and Practice
Published
2026-11-18
DOI
https://doi.org/10.3390/clinpract16110218
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study

Elakiya Jayaraman, Shilpa Chitnis, Akriti Agrawal, Mahnoor Mir et al.
2 links
Clinics and Practice
Multiple Sclerosis Research Studies
article

Epidemiologic Analysis of Mortality Predictors and Readmissions in Patients with Transverse Myelitis and/or Acute Disseminated Encephalomyelitis: A Nationwide Readmissions Database Study

Elakiya Jayaraman, Shilpa Chitnis, Akriti Agrawal, Mahnoor Mir, Elsbeth Chow, Alisha Young, Trishna Parikh, RISHI PANJALA, ARNAV GARYALI, Adishwar Rao, Saahith Garg, Dhriti Kumar, Dhruv Kumar, Ananya Surabhi
article en

Abstract

Background/Objectives: Transverse myelitis (TM) and acute disseminated encephalomyelitis (ADEM) are debilitating neurological conditions. We aimed to examine in-hospital mortality and readmissions in patients hospitalized with TM and/or ADEM. Methods: In this retrospective study, we analyzed the Nationwide Readmissions Database from 2010 to 2020, excluding 2015, to identify index hospitalizations for TM and/or ADEM. Patients were stratified according to in-hospital mortality status. We used the Pearson chi-square test and Wilcoxon rank-sum test to compare baseline characteristics, while multivariable logistic regression analysis was used to identify predictors of in-hospital mortality. Results: Of 50,357 patients hospitalized with TM and/or ADEM, 1236 (2.5%) did not survive index hospitalization. Nonsurvivors were older with longer lengths of stay and a higher comorbidity burden. Among those ≥45 years, there was a trend towards increased odds of in-hospital mortality. Infection-related factors were associated with increased odds of in-hospital mortality, including streptococcal infection (odds ratio [OR]: 5.45 [1.07–27.68], p = 0.04) and coronavirus disease 2019 (OR: 4.54 [2.51–8.19], p < 0.001). Stroke (OR 2.71 [2.11–3.48], p < 0.001) and congestive heart failure (OR 2.17 [1.66–2.85], p < 0.001) emerged as the strongest predictors amongst chronic comorbidities. Over the study period, 5301 (11.8%) patients were readmitted to the hospital within 30 days. Conclusions: In patients with TM and/or ADEM, in-hospital mortality was associated with older age, greater comorbidity burden, and concurrent infections, particularly COVID-19 and streptococcal infections. These findings highlight opportunities for prevention, early detection, and management strategies to improve outcomes for patients with TM and/or ADEM.

Clinics and PracticeVol. 16(11)
Baylor College of Medicine (US), University Hospitals of Cleveland (US), Guthrie Robert Packer Hospital (US), The University of Texas Health Science Center (US), Case Western Reserve University (US), Rice University (US), The University of Texas at Austin (US), The University of Texas Health Science Center at Tyler (US), The University of Texas Health Science Center at Houston (US)
Good health and well-being
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon